Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Xylem
XYL
$23.8B
| $24.3M | 0.03% |
187,671
-314,600
| -63% | -$38.1M |
2024 Q3
3 quarters
|
|
627
Carriage Services
CSV
$531M
| $24.1M | 0.03% |
526,700
+13,800
| +3% | +$576K |
2013 Q2
48 quarters
|
|
628
Yum China
YUMC
$14.5B
| $24M | 0.03% |
+536,500
| New | +$24M |
2025 Q2
0 quarters
|
|
|
AVB
629
DELISTED
AvalonBay Communities
AVB
| $23.9M | 0.03% |
+117,577
| New | +$24M |
2025 Q2
0 quarters
|
|
|
CSAN
630
DELISTED
Cosan
CSAN
| $23.7M | 0.03% |
4,693,982
+250,700
| +6% | +$1.35M |
2021 Q1
17 quarters
|
|
631
Regeneron Pharmaceuticals
REGN
$77.1B
| $23.7M | 0.03% |
45,062
-33,839
| -43% | -$18.9M |
2021 Q3
15 quarters
|
|
632
Amkor Technology
AMKR
$12.3B
| $23.6M | 0.03% |
1,125,100
-244,600
| -18% | -$4.51M |
2024 Q4
2 quarters
|
|
633
Zebra Technologies
ZBRA
$18.2B
| $23.6M | 0.03% |
76,531
-198,800
| -72% | -$54M |
2024 Q2
4 quarters
|
|
634
Remitly
RELY
$5B
| $23.6M | 0.03% |
1,256,401
+839,254
| +201% | +$17.5M |
2023 Q4
6 quarters
|
|
635
Crown Castle
CCI
$33.2B
| $23.5M | 0.03% |
+229,103
| New | +$23.2M |
2025 Q2
0 quarters
|
|
636
Goodyear
GT
$1.36B
| $23.4M | 0.03% |
+2,256,754
| New | +$23.9M |
2025 Q2
0 quarters
|
|
637
QCR Holdings
QCRH
$1.59B
| $23.3M | 0.03% |
343,772
+24,900
| +8% | +$1.66M |
2014 Q1
45 quarters
|
|
638
Lowe's Companies
LOW
$104B
| $23.3M | 0.03% |
105,201
-63,129
| -38% | -$14.1M |
2024 Q3
3 quarters
|
|
639
Legend Biotech
LEGN
$3.67B
| $23.3M | 0.03% |
656,300
-54,600
| -8% | -$1.77M |
2024 Q3
3 quarters
|
|
|
GOOD
640
Gladstone Commercial Corp
GOOD
$611M
| $23.2M | 0.03% |
1,620,054
+171,500
| +12% | +$2.43M |
2014 Q1
45 quarters
|
|
641
Curtiss-Wright
CW
$18.8B
| $23.2M | 0.03% |
47,500
-11,500
| -19% | -$4.54M |
2023 Q3
7 quarters
|
|
642
Ambarella
AMBA
$2.93B
| $23.2M | 0.03% |
350,849
-6,851
| -2% | -$363K |
2024 Q4
2 quarters
|
|
643
NovoCure
NVCR
$1.7B
| $23.1M | 0.03% |
1,300,054
+531,400
| +69% | +$9.26M |
2023 Q4
6 quarters
|
|
644
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.8B
| $23.1M | 0.03% |
968,800
-243,257
| -20% | -$5.66M |
2023 Q1
9 quarters
|
|
645
Tanger
SKT
$3.99B
| $22.8M | 0.03% |
746,772
-157,300
| -17% | -$4.82M |
2021 Q3
15 quarters
|
|
|
CVSA
646
Covista Inc
CVSA
$4.43B
| $22.8M | 0.03% |
179,400
-30,300
| -14% | -$3.58M |
2022 Q4
10 quarters
|
|
647
HubSpot
HUBS
$11.5B
| $22.8M | 0.03% |
41,000
+39,900
| +3,627% | +$23.4M |
2022 Q2
12 quarters
|
|
648
Bank of Montreal
BMO
$112B
| $22.8M | 0.03% |
205,895
+160,700
| +356% | +$16.2M |
2025 Q1
1 quarter
|
|
649
Unitil
UTL
$954M
| $22.7M | 0.03% |
434,440
+1,900
| +0.4% | +$105K |
2013 Q2
48 quarters
|
|
650
Payoneer
PAYO
$2.42B
| $22.7M | 0.03% |
3,307,200
-797,700
| -19% | -$5.41M |
2022 Q1
13 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.